Adherence and patients’ experiences with capecitabine.
Ontology highlight
ABSTRACT: Interventions: The use of capecitabine in daily practice will be monitored for 5 cycles. Every cycle takes three weeks.
Primary outcome(s): Adherence rate: A patient is adherent with the intake of 85% or more of the prescribed medication.
Study Design: N/A: single arm study, N/A , unknown, Parallel
DISEASE(S): Colorectal Cancer, Gastric Cancer And Breast Cancer
PROVIDER: 16613 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA